Abstract
The efforts of the Human Genome Project have resulted in, among other things, the identification and mapping of hundreds of thousands of anonymous single nucleotide polymorphisms (SNPs) for use in genome-wide association studies. The successful application of SNP maps to finding genes that underlie common diseases and drug responses depends, in part, on the extent of linkage disequilibrium (LD) in the population under study. Linkage disequilibrium, or correlation between polymorphisms located in close proximity to each other, allows anonymous polymorphisms throughout the entire genome to be tested for their association with disease and/or drug response. Through LD, these anonymous SNPs can pinpoint genomic regions that might harbor the true, causative genetic variants that underlie the association with disease and drug response. Until recently, the extent of LD, or distance over which two genetic variants could be separated and still be correlated, was poorly understood and the feasibility of such LD mapping approaches uncertain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.